Clinical Trial Update: Breast Cancer Risk Biomarkers in Premenopausal Women [Phase 2]

View source ↗

Summary

This document reports the results of a Phase 2 clinical trial evaluating breast cancer risk biomarkers in premenopausal women. Results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Carol Fabian, MD | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-07-21